Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 3, 2008

View Archived Issues

Targeting galectin-1 may be useful to prevent pregnancy loss

Studies support serotonin inverse agonist combination therapy for schizophrenia

New site-directed nanoparticle delivery system useful to treat ocular inflammation in vivo

Cognition-enhancing activity of novel inverse agonist of GABA-A alpha 5 subunit receptors

Modulation of LR11 protein levels by dietary DHA may be beneficial for AD prevention

AstraZeneca submits sNDAs for Seroquel XR tablets

Can-Fite collaborates with academic institutes to develop CF-102

Efexor XL indication in U.K. now includes moderate-severe generalized SAD/social phobia

Innocoll doses first patient in phase III gentamicin surgical implant trial

NeoPharm files IND for novel docetaxel liposomal delivery system

Pfizer completes tender offer relating to outstanding shares of Coley Pharmaceutical

Recent Jerini patent discloses novel agents for ocular disorders

Pfizer launches Ecalta for invasive candidiasis in non-neutropenic patients

Positive results reported for Zybrestat in platinum-resistant ovarian cancer

Prana Biotechnology completes phase IIa trial of PBT-2 in Alzheimer's disease

Recent patents impart novel analgesic agents

FDA approves Sciele Pharma's new Sular formulation

FDA assigns priority review status to Schering-Plough's NDA for sugammadex

New HIV aspartyl protease inhibitors disclosed in recent Tibotec patent

Recent patents describe new antidiabetic agents

Sepracor and Bial collaborate on antiepileptic compound in U.S. and Canada

Positive preclinical ocular penetration data reported for topical Zybrestat in ophthalmology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...